Changing Survival Rate of Infants Born Before 26 Gestational Weeks: Single-centre study

Asad Rahman1, Mohamed Abdellatif1, Sharef W Sharef1

  • 1Department of Child Health, Sultan Qaboos University Hospital, Muscat, Oman.

Insights

Survival rates for extremely premature infants born before 26 weeks gestational age have significantly improved. This study highlights better outcomes for these vulnerable newborns at Sultan Qaboos University Hospital.

Area of Science:

  • Neonatalogy
  • Perinatology
  • Public Health

Background:

  • Extremely preterm infants (born before 26 weeks gestational age) face high mortality and morbidity risks.
  • Evaluating survival trends and associated morbidities is crucial for improving neonatal care.
  • Previous data from Sultan Qaboos University Hospital (SQUH) indicated lower survival rates for this population.

Purpose of the Study:

  • To assess the contemporary survival rates of infants born between 23-26 gestational weeks at SQUH.
  • To identify and quantify major morbidities in this cohort.
  • To compare current outcomes with historical data from the same institution.

Main Methods:

  • Retrospective analysis of 81 infants born between 23-26 gestational weeks at SQUH (June 2006 - May 2013).
  • Inclusion of infants referred within 72 hours of birth.
  • Review of electronic records for demographics, clinical data, morbidities, and outcomes; comparison with 1991-1998 data.

Main Results:

  • Overall survival rate was 60.5% (49 out of 81 infants), a significant increase from 41% in the previous study.
  • Common morbidities included respiratory distress syndrome (100%), retinopathy of prematurity (51.9%), bronchopulmonary dysplasia (34.6%), intraventricular hemorrhage (30.9%), and patent ductus arteriosus (28.4%).
  • Male infants constituted 58.0% of the cohort, with a median gestational age of 25 weeks and mean birth weight of 770g.

Conclusions:

  • Survival rates for extremely preterm infants (23-26 weeks gestational age) have significantly improved at SQUH.
  • Despite improved survival, common morbidities persist, necessitating continued vigilance and care.
  • Long-term neurodevelopmental follow-up for these infants is recommended to fully assess outcomes.
Abstract

Related Concept Videos